Norway Savings Bank’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,148
| Closed | -$217K | – | 141 |
|
|
2023
Q4 | $217K | Sell |
2,148
-135
| -6% | -$13K | 0.1% | 134 |
|
|
2023
Q3 | $233K | Sell |
2,283
-175
| -7% | -$17.8K | 0.11% | 123 |
|
|
2023
Q2 | $248K | Sell |
2,458
-690
| -22% | -$69K | 0.14% | 111 |
|
|
2023
Q1 | $290K | Sell |
3,148
-450
| -13% | -$39.3K | 0.15% | 118 |
|
|
2022
Q4 | $326K | Sell |
3,598
-255
| -7% | -$21.5K | 0.17% | 115 |
|
|
2022
Q3 | $293K | Sell |
3,853
-815
| -17% | -$67.6K | 0.16% | 116 |
|
|
2022
Q2 | $394K | Sell |
4,668
-905
| -16% | -$79.4K | 0.2% | 110 |
|
|
2022
Q1 | $489K | Sell |
5,573
-405
| -7% | -$35.1K | 0.22% | 108 |
|
|
2021
Q4 | $523K | Sell |
5,978
-2,565
| -30% | -$213K | 0.23% | 101 |
|
|
2021
Q3 | $699K | Sell |
8,543
-1,490
| -15% | -$134K | 0.33% | 82 |
|
|
2021
Q2 | $915K | Sell |
10,033
-2,215
| -18% | -$197K | 0.45% | 69 |
|
|
2021
Q1 | $1.05M | Sell |
12,248
-125
| -1% | -$11.2K | 0.55% | 61 |
|
|
2020
Q4 | $1.17M | Sell |
12,373
-70
| -0.6% | -$6.12K | 0.67% | 50 |
|
|
2020
Q3 | $1.08M | Sell |
12,443
-155
| -1% | -$13.4K | 0.73% | 43 |
|
|
2020
Q2 | $1.1M | Buy |
12,598
+115
| +0.9% | +$9.93K | 0.81% | 43 |
|
|
2020
Q1 | $1.03M | Buy |
12,483
+10
| +0.1% | +$892 | 0.9% | 35 |
|
|
2019
Q4 | $1.18M | Sell |
12,473
-100
| -0.8% | -$8.97K | 0.86% | 36 |
|
|
2019
Q3 | $1.09M | Buy |
12,573
+130
| +1% | +$11.7K | 0.89% | 35 |
|
|
2019
Q2 | $1.14M | Sell |
12,443
-980
| -7% | -$82.9K | 0.97% | 33 |
|
|
2019
Q1 | $1.16M | Buy |
13,423
+591
| +5% | +$47.4K | 1.02% | 32 |
|
|
2018
Q4 | $986K | Sell |
12,832
-273
| -2% | -$21.3K | 0.97% | 32 |
|
|
2018
Q3 | $1.01M | Sell |
13,105
-1,190
| -8% | -$88K | 0.88% | 35 |
|
|
2018
Q2 | $968K | Buy |
14,295
+402
| +3% | +$27.7K | 0.88% | 34 |
|
|
2018
Q1 | $1.01M | Sell |
13,893
-609
| -4% | -$46.4K | 0.95% | 32 |
|
|
2017
Q4 | $1.09M | Sell |
14,502
-318
| -2% | -$24K | 1.02% | 30 |
|
|
2017
Q3 | $1.14M | Sell |
14,820
-134
| -0.9% | -$10.1K | 1.09% | 28 |
|
|
2017
Q2 | $1.12M | Buy |
14,954
+820
| +6% | +$58.1K | 1.09% | 27 |
|
|
2017
Q1 | $941K | Sell |
14,134
-4,855
| -26% | -$324K | 0.97% | 31 |
|
|
2016
Q4 | $1.24M | Buy |
+18,989
| New | +$1.23M | 1.15% | 29 |
|
Other funds holding NVS
Norway Savings Bank's NVS Position: Q1 2024 in Review
Norway Savings Bank sold out of Novartis (NVS) in Q1 2024, closing a stake of 2,148 shares — an estimated $217K sold.
Norway Savings Bank first reported a position in NVS in Q4 2016 and held it in 29 quarters. The position peaked at $1.24M in Q4 2016. 1,253 funds tracked by Wall St. Rank hold NVS as of Q1 2024.
- Norway Savings Bank reported no remaining Novartis position as of Q1 2024 after selling out during the quarter.
- Norway Savings Bank sold 2,148 Novartis shares in Q1 2024, an estimated $217K.
- Norway Savings Bank first reported a position in Novartis in Q4 2016 and held it in 29 quarters.
- Norway Savings Bank's Novartis position peaked at $1.24M in Q4 2016.
- 1,253 funds tracked by Wall St. Rank held Novartis as of Q1 2024.
Based on Norway Savings Bank's 13F filing for Q1 2024, filed 16 Apr 2024.